How to treat brain metastasis in 2012?;Métastases cérébrales : Quelle prise en charge en 2012 ?

Cancer/Radiotherapie

Volumn 16, Issue 4, 2012, Pages 309-314

  Braccini, A L ^a   Azria, D ^a   Mazeron, J J ^b   Mornex, F ^c   Jacot, W ^a   Metellus, P ^d   Tallet, A ^e  

^a CENTRE VAL D AURELLE   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

^e INSTITUT PAOLI CALMETTES   (France)

Author keywords

Breast cancer; Stereotactic radiotherapy; Surgery; Whole brain radiotherapy

Indexed keywords

BRAIN METASTASIS; BREAST CANCER; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; COGNITION; HIPPOCAMPUS; HUMAN; NEUROTOXICITY; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; SHORT SURVEY; STEREOTACTIC PROCEDURE; TUMOR VOLUME;

BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; RADIOSURGERY;

EID: 84864764735     PISSN: 12783218     EISSN: 17696658     Source Type: Journal    
DOI: 10.1016/j.canrad.2012.03.010     Document Type: Short Survey

References (58)

1. Patchell R.A., Tibbs P.A., Walsh J.W., Dempsey R.J., Maruyama Y., Kryscio R.J., et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990, 322:494-500.
2. Vecht C.J., Haaxma-Reiche H., Noordijk E.M., Padberg G.W., Voormolen J.H., Hoekstra F.H., et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?. Ann Neurol 1993, 33:583-590.
3. Noordijk E.M., Vecht C.J., Haaxma-Reiche H., Padberg G.W., Voormolen J.H., Hoekstra F.H., et al. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys 1994, 29:711-717.
4. Ampil F.L., Sanghani S.V. Timing of radiotherapy in asymptomatic patients with inoperable non-small cell lung cancer: a survival analysis and literature review. Radiat Med 1996, 14:211-214.
5. Rades D., Kueter J.D., Pluemer A., Veninga T., Schild S.E. A matched-pair analysis comparing whole brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole brain radiotherapy and a boost to the metastatic site for one or two brain metastases. Int J Radiat Oncol Biol Phys 2009, 73:1077-1081.
6. Sause W.T., Crowley J.J., Morantz R., Rotman M., Mowry P.A., Bouzaglou A., et al. Solitary brain metastasis: results of an RTOG/SWOG protocol evaluation surgery+RT versus RT alone. Am J Clin Oncol 1990, 13:427-432.
7. Mintz A.H., Kestle J., Rathbone M.P., Gaspar L., Hugenholtz H., Fisher B., et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996, 78:1470-1476.
8. Gaspar L.E., Mehta M.P., Patchell R.A., Burri S.H., Robinson P.D., Morris R.E., et al. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010, 96:17-32.
9. Stark A.M., Tscheslog H., Buhl R., Held-Feindt J., Mehdorn H.M. Surgical treatment for brain metastases: prognostic factors and survival in 177 patients. Neurosurg Rev 2005, 28:115-119.
10. Paek S.H., Audu P.B., Sperling M.R., Cho J., Andrews D.W. Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery 2005, 56:1021-1034. [discussion p. 1034].
11. Schlienger M., Nataf F., Huguet F., Pene F., Foulquier J.N., Orthuon A., et al. Place de l'irradiation stéréotaxique hypofractionnée dans le traitement des métastases cérébrales. Cancer Radiother 2010, 14:119-127.
12. Andrews D.W., Scott C.B., Sperduto P.W., Flanders A.E., Gaspar L.E., Schell M.C., et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363:1665-1672.
13. Kondziolka D., Patel A., Lunsford L.D., Kassam A., Flickinger J.C. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999, 45:427-434.
14. Sanghavi S.N., Miranpuri S.S., Chappell R., Buatti J.M., Sneed P.K., Suh J.H., et al. Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 2001, 51:426-434.
15. Linskey M.E., Andrews D.W., Asher A.L., Burri S.H., Kondziolka D., Robinson P.D., et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010, 96:45-68.
16. Patil C.G., Pricola K., Garg S.K., Bryant A., Black K.L. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. Cochrane Database Syst Rev 2010, 6:CD006121.
17. Lévy A., Chargari C., Lamproglou I., Mazeron J.J., Krzisch C., Assouline A. Expérience de l'irradiation encéphalique totale avec escalade de dose focalisée pour le traitement des métastases cérébrales uniques d'un carcinome bronchopulmonaire. Cancer Radiother 2011, 15:426-429.
18. Flickinger J.C., Kondziolka D., Lunsford L.D., Coffey R.J., Goodman M.L., Shaw E.G., et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 1994, 28:797-802.
19. Alexander E., Moriarty T.M., Davis R.B., Wen P.Y., Fine H.A., Black P.M., et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 1995, 87:34-40.
20. Goodman K.A., Sneed P.K., McDermott M.W., Shiau C.Y., Lamborn K.R., Chang S., et al. Relationship between pattern of enhancement and local control of brain metastases after radiosurgery. Int J Radiat Oncol Biol Phys 2001, 50:139-146.
21. Mehta M.P., Tsao M.N., Whelan T.J., Morris D.E., Hayman J.A., Flickinger J.C., et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2005, 63:37-46.
22. Noël G., Bollet M.A., Noël S., Feuvret L., Boisserie G., Tep B., et al. Linac stereotactic radiosurgery: an effective and safe treatment for elderly patients with brain metastases. Int J Radiat Oncol Biol Phys 2005, 63:1555-1561.
23. Noël G., Medioni J., Valéry C.A., Boisserie G., Simon J.M., Cornu P., et al. Three irradiation treatment options including radiosurgery for brain metastases from primary lung cancer. Lung Cancer 2003, 41:333-343.
24. Noël G., Simon J.M., Valéry C.A., Cornu P., Boisserie G., Ledu D., et al. Linac radiosurgery for brain metastasis of melanoma. Stereotact Funct Neurosurg 2002, 79:245-255.
25. Noël G., Valéry C.A., Boisserie G., Cornu P., Hasboun D., Marc Simon J., et al. Linac radiosurgery for brain metastasis of renal cell carcinoma. Urol Oncol 2004, 22:25-31.
26. Noël G., Mazeron J.J. Réirradiation cérébrale des tumeurs primitives malignes ou secondaires. Cancer Radiother 2010, 14:421-437.
27. Garell P., Hitchon P., Wen B., Mellenberg D., Torner J. Stereotactic radiosurgery versus microsurgical resection for the initial treatment of metastatic cancer to the brain. J Radiosurg 1999, 2:1-5.
28. Schoggl A., Kitz K., Reddy M., Wolfsberger S., Schneider B., Dieckmann K., et al. Defining the role of stereotactic radiosurgery versus microsurgery in the treatment of single brain metastases. Acta Neurochir (Wien) 2000, 142:621-626.
29. O'Neill B.P., Iturria N.J., Link M.J., Pollock B.E., Ballman K.V., O'Fallon J.R. A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys 2003, 55:1169-1176.
30. ® surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol 2008, 87:299-307.
31. Auperin A., Arriagada R., Pignon J.P., Le Péchoux C., Gregor A., Stephens R.J., et al. Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission. N Engl J Med 1999, 341:476-484.
32. Patchell R.A., Tibbs P.A., Regine W.F., Dempsey R.J., Mohiuddin M., Kryscio R.J., et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998, 280:1485-1489.
33. Aoyama H., Shirato H., Tago M., Nakagawa K., Toyoda T., Hatano K., et al. Stereotactic radiosurgery plus whole brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006, 295:2483-2491.
34. Pirzkall A., Debus J., Lohr F., Fuss M., Rhein B., Engenhart-Cabillic R., et al. Radiosurgery alone or in combination with whole brain radiotherapy for brain metastases. J Clin Oncol 1998, 16:3563-3569.
35. Chidel M.A., Suh J.H., Reddy C.A., Chao S.T., Lundbeck M.F., Barnett G.H. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases. Int J Radiat Oncol Biol Phys 2000, 47:993-999.
36. Kocher M., Soffietti R., Abacioglu U., Villa S., Fauchon F., Baumert B.G., et al. Adjuvant whole brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 2011, 29:134-141.
37. Roberge D., Parney I., Brown P.D. Radiosurgery to the postoperative surgical cavity: who needs evidence?. Int J Radiat Oncol Biol Phys 2012, 83:486-493.
38. Li J., Bentzen S.M., Renschler M., Mehta M.P. Regression after whole brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol 2007, 25:1260-1266.
39. Meyers C.A., Smith J.A., Bezjak A., Mehta M.P., Liebmann J., Illidge T., et al. Neurocognitive function and progression in patients with brain metastases treated with whole brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 2004, 22:157-165.
40. Armstrong C., Ruffer J., Corn B., DeVries K., Mollman J. Biphasic patterns of memory deficits following moderate-dose partial-brain irradiation: neuropsychologic outcome and proposed mechanisms. J Clin Oncol 1995, 13:2263-2271.
41. Acharya M.M., Christie L.A., Lan M.L., Giedzinski E., Fike J.R., Rosi S., et al. Human neural stem cell transplantation ameliorates radiation-induced cognitive dysfunction. Cancer Res 2011, 71:4834-4845.
42. Monje M.L., Palmer T. Radiation injury and neurogenesis. Curr Opin Neurol 2003, 16:129-134.
43. Gondi V., Tome W.A., Mehta M.P. Why avoid the hippocampus? A comprehensive review. Radiother Oncol 2010, 97:370-376.
44. Abayomi O.K. Pathogenesis of cognitive decline following therapeutic irradiation for head and neck tumors. Acta Oncol 2002, 41:346-351.
45. Gondi V., Tolakanahalli R., Mehta M.P., Tewatia D., Rowley H., Kuo J.S., et al. Hippocampal-sparing whole brain radiotherapy: a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2010, 78:1244-1252.
46. Gutierrez A.N., Westerly D.C., Tome W.A., Jaradat H.A., Mackie T.R., Bentzen S.M., et al. Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study. Int J Radiat Oncol Biol Phys 2007, 69:589-597.
47. Hsu F., Carolan H., Nichol A., Cao F., Nuraney N., Lee R., et al. Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for 1-3 brain metastases: a feasibility study using volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys 2010, 76:1480-1485.
48. Robinet G., Thomas P., Breton J.L., Lena H., Gouva S., Dabouis G., et al. Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small cell lung cancer: groupe français de pneumocancerologie (GFPC) Protocol 95-1. Ann Oncol 2001, 12:59-67.
49. Boogerd W., Dalesio O., Bais E.M., van der Sande J.J. Response of brain metastases from breast cancer to systemic chemotherapy. Cancer 1992, 69:972-980.
50. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., et al. Molecular portraits of human breast tumours. Nature 2000, 406:747-752.
51. Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001, 98:10869-10874.
52. Sotiriou C., Neo S.Y., McShane L.M., Korn E.L., Long P.M., Jazaeri A., et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A 2003, 100:10393-10398.
53. Hu Z., Fan C., Oh D.S., Marron J.S., He X., Qaqish B.F., et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 2006, 7:96.
54. Anders C.K., Deal A.M., Miller C.R., Khorram C., Meng H., Burrows E., et al. The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases. Cancer 2011, 117:1602-1611.
55. Nam B.H., Kim S.Y., Han H.S., Kwon Y., Lee K.S., Kim T.H., et al. Breast cancer subtypes and survival in patients with brain metastases. Breast Cancer Res 2008, 10:R20.
56. Dawood S., Broglio K., Esteva F.J., Ibrahim N.K., Kau S.W., Islam R., et al. Defining prognosis for women with breast cancer and CNS metastases by HER2 status. Ann Oncol 2008, 19:1242-1248.
57. Niwinska A., Murawska M., Pogoda K. Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole brain radiotherapy (WBRT). Ann Oncol 2010, 21:942-948.
58. Stemmler H.J., Schmitt M., Willems A., Bernhard H., Harbeck N., Heinemann V. Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier. Anticancer Drugs 2007, 18:23-28.